The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing, Issue of Equity and TVR

14 Feb 2022 07:00

RNS Number : 5108B
Microsaic Systems plc
14 February 2022
 

14 February 2022

 

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Director Dealing, Issue of Equity and Total Voting Rights

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, announces that it will issue 85,000,000 ordinary shares in the Company (the "Fee Shares") to certain of the Company's directors in respect of their annual remuneration for their second year of service, paid in advance, as outlined in the Company's announcement of 19 January 2021.

 

In addition, the Company received notice from Dr Nigel Burton, Non-Executive Director of the Company of his intention to exercise warrants ("Warrants") relating to 200,000,000 ordinary shares, reflecting an investment of £200,000 in the Company. The Warrants were granted in conjunction with the fundraise completed by the Company in February 2021 (the "Fundraise") at an exercise price of 0.1p, being the Fundraise issue price.

 

Gerry Brandon, Non-executive Chairman of Microsaic Systems, commented:

"The exercise of warrants and investment of £200,000 by Dr. Nigel Burton, Non-executive Director, and our receipt of share based remuneration in lieu of our respective salaries for the second year, represent a strong signal of our full support for Microsaic and the commercial potential to come from its under-exploited technology. It also reflects our continuing belief in the quality of the Microsaic team, whose capabilities and expertise continue to impress."

 

Application has been made to the London Stock Exchange for 285,000,000 ordinary shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 am. on or around 17 February 2022.

 

Director

Position

Annual Remuneration

Number of Fee Shares to be issued

Number of Ordinary Shares issued pursuant to Warrants exercised

Number of Ordinary Shares held on Admission

% of issued share capital held on Admission

Gerard Brandon

Non-Executive Chairman

£50,000

50,000,000

-

190,000,000

2.99

Nigel Burton

Non-Executive Director

£35,000

35,000,000

200,000,000

300,500,000

4.72

 

Total voting rights

 

Following Admission, the Company will have 6,361,365,146 ordinary shares in issue. The Company does not hold any shares in treasury. Therefore, from Admission, the total voting rights in the Company will be 6,361,365,146.

 

From Admission, the figure of 6,361,365,146 may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

About Microsaic

 

Microsaic develops and commercialises globally micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need: whether within a human health environment; conventional laboratory setting; within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow; or in front-line environmental monitoring.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

Details of the person discharging managerial responsibilities / person closely associated

a) 

Name

Gerard Brandon

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares in lieu of annual remuneration (Fee Shares)

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

50,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Dr Nigel Burton

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares in lieu of annual remuneration (Fee Shares)

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

35,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Dr Nigel Burton

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares pursuant to exercise of warrants

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

200,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUACPUPPPGW
Date   Source Headline
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.